Mingjun Li

467 total citations
17 papers, 170 citations indexed

About

Mingjun Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mingjun Li has authored 17 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Mingjun Li's work include Lung Cancer Treatments and Mutations (5 papers), Circular RNAs in diseases (3 papers) and Extracellular vesicles in disease (2 papers). Mingjun Li is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Circular RNAs in diseases (3 papers) and Extracellular vesicles in disease (2 papers). Mingjun Li collaborates with scholars based in China. Mingjun Li's co-authors include Ningning Yan, Xingya Li, Wengang Wang, Xiaofei Zhang, Xiaofei Zhang, Benling Xu, Yongxu Jia, Yanru Qin, Huijie Fan and Xudong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Cellular Biochemistry and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Mingjun Li

15 papers receiving 168 citations

Peers

Mingjun Li
Minghe Li China
Ünal Metin Tokat Türkiye
Yexuan Deng China
Chengxuan Yu China
Prabhakar Pitta Venkata United States
Ghazaleh Pourali Iran
Rosa Jorge Spain
Yiming He China
Jipeng Wang China
Minghe Li China
Mingjun Li
Citations per year, relative to Mingjun Li Mingjun Li (= 1×) peers Minghe Li

Countries citing papers authored by Mingjun Li

Since Specialization
Citations

This map shows the geographic impact of Mingjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Li more than expected).

Fields of papers citing papers by Mingjun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Li. The network helps show where Mingjun Li may publish in the future.

Co-authorship network of co-authors of Mingjun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjun Li. A scholar is included among the top collaborators of Mingjun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjun Li. Mingjun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Mingjun, Yan Zhou, Shichang Li, et al.. (2025). Unveiling Stable and Efficient Antiperovskite Semiconductors via High-Throughput Computation and Interpretable Machine Learning. Chinese Physics B. 1 indexed citations
2.
3.
Li, Mingjun, et al.. (2025). Knowledge transfer from simple to complex: A safe and efficient reinforcement learning framework for autonomous driving decision-making. Advanced Engineering Informatics. 65. 103188–103188. 1 indexed citations
4.
Ai, Xinghao, Yunyan Zhang, Tongmei Zhang, et al.. (2025). A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer.. Journal of Clinical Oncology. 43(16_suppl). 8007–8007. 2 indexed citations
5.
6.
7.
Zhao, Shen, Hongyun Zhao, Li Zhang, et al.. (2024). Phase I trial of aurora kinase A (AURKA) inhibitor VIC-1911 plus osimertinib for TKI-resistant, EGFR-mutant non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8077–8077. 1 indexed citations
8.
Duan, Jianchun, Jun Zhao, Zhang Li, et al.. (2023). Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations.. Journal of Clinical Oncology. 41(16_suppl). 9014–9014. 2 indexed citations
9.
Yang, Jin‐Ji, Jianying Zhou, Ying Cheng, et al.. (2022). SAF-189s in advanced, ALK-positive, non–small cell lung cancer: Results from a first-in-human phase 1/2, multicenter study.. Journal of Clinical Oncology. 40(16_suppl). 9076–9076. 5 indexed citations
10.
11.
Li, Mingjun, et al.. (2021). CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p. Cell Cycle. 20(13). 1279–1294. 23 indexed citations
12.
Li, Mingjun, et al.. (2020). Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6. Cancer Cell International. 20(1). 574–574. 25 indexed citations
13.
Fan, Huijie, Jing Li, Yongxu Jia, et al.. (2017). Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 25(7). 1061–1068. 29 indexed citations
14.
Wang, Wengang, Mingjun Li, Mingkui Shen, et al.. (2017). Naringenin inhibits osteoclastogenesis through modulation of helper T cells‐secreted IL‐4. Journal of Cellular Biochemistry. 119(2). 2084–2093. 18 indexed citations
15.
Li, Mingjun, Wengang Wang, Yanru Qin, et al.. (2015). Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis. International Journal of Molecular Medicine. 36(5). 1335–1344. 30 indexed citations
16.
Zhao, Caiyan, Xiaoguang Liu, Junxing Liu, et al.. (2014). Transferrin conjugated poly (γ-glutamic acid-maleimide-co- l -lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery. Colloids and Surfaces B Biointerfaces. 123. 787–796. 16 indexed citations
17.
Fan, Huijie, Benling Xu, Jingjing Wu, et al.. (2012). Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. Tumor Biology. 34(2). 769–778. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghe Li Breakdown of academic impact, for papers by Ünal Metin Tokat Breakdown of academic impact, for papers by Yexuan Deng Breakdown of academic impact, for papers by Chengxuan Yu Breakdown of academic impact, for papers by Prabhakar Pitta Venkata Breakdown of academic impact, for papers by Ghazaleh Pourali Breakdown of academic impact, for papers by Rosa Jorge Breakdown of academic impact, for papers by Yiming He Breakdown of academic impact, for papers by Jipeng Wang
Rankless by CCL
2026